PERIMETER MEDICAL IMAGING AI (PINK.CA) Stock Fundamental Analysis
TSX-V:PINK - TSX Venture Exchange - CA71385D1078 - Common Stock - Currency: CAD
We assign a fundamental rating of 3 out of 10 to PINK. PINK was compared to 16 industry peers in the Health Care Equipment & Supplies industry. PINK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PINK is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
PINK had negative earnings in the past year.
PINK had a negative operating cash flow in the past year.
PINK had negative earnings in each of the past 5 years.
PINK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
PINK has a Return On Assets of -93.49%. This is in the better half of the industry: PINK outperforms 62.50% of its industry peers.
Looking at the Return On Equity, with a value of -128.11%, PINK is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -93.49% | ||
| ROE | -128.11% | ||
| ROIC | N/A |
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PINK's Gross Margin of 63.24% is amongst the best of the industry. PINK outperforms 81.25% of its industry peers.
In the last couple of years the Gross Margin of PINK has grown nicely.
PINK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.24% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
2. Health
2.1 Basic Checks
PINK does not have a ROIC to compare to the WACC, probably because it is not profitable.
PINK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, PINK has more shares outstanding
PINK has a worse debt/assets ratio than last year.
2.2 Solvency
PINK has an Altman-Z score of -8.11. This is a bad value and indicates that PINK is not financially healthy and even has some risk of bankruptcy.
PINK has a Altman-Z score (-8.11) which is in line with its industry peers.
A Debt/Equity ratio of 0.01 indicates that PINK is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.01, PINK belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.11 |
ROIC/WACCN/A
WACC7.63%
2.3 Liquidity
PINK has a Current Ratio of 2.79. This indicates that PINK is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.79, PINK belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
A Quick Ratio of 2.73 indicates that PINK has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.73, PINK belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.79 | ||
| Quick Ratio | 2.73 |
3. Growth
3.1 Past
PINK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.32%.
Looking at the last year, PINK shows a very strong growth in Revenue. The Revenue has grown by 109.64%.
EPS 1Y (TTM)-56.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.94%
Revenue 1Y (TTM)109.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%464.19%
3.2 Future
The Earnings Per Share is expected to grow by 9.22% on average over the next years. This is quite good.
Based on estimates for the next years, PINK will show a very strong growth in Revenue. The Revenue will grow by 106.53% on average per year.
EPS Next Y16.12%
EPS Next 2Y2.32%
EPS Next 3Y7.1%
EPS Next 5Y9.22%
Revenue Next Year14.85%
Revenue Next 2Y106.36%
Revenue Next 3Y129.71%
Revenue Next 5Y106.53%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for PINK. In the last year negative earnings were reported.
Also next year PINK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.32%
EPS Next 3Y7.1%
5. Dividend
5.1 Amount
No dividends for PINK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:PINK (4/30/2025, 7:00:00 PM)
0.39
+0.01 (+1.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners33.18%
Inst Owner ChangeN/A
Ins Owners13.82%
Ins Owner ChangeN/A
Market Cap36.47M
Analysts80
Price Target2.04 (423.08%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.33%
Min Revenue beat(2)1.49%
Max Revenue beat(2)3.17%
Revenue beat(4)3
Avg Revenue beat(4)9.21%
Min Revenue beat(4)-34.65%
Max Revenue beat(4)66.83%
Revenue beat(8)4
Avg Revenue beat(8)-13.11%
Revenue beat(12)5
Avg Revenue beat(12)-24.53%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)31.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 31.17 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.52 | ||
| P/tB | 2.52 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.41
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0.01
BVpS0.15
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -93.49% | ||
| ROE | -128.11% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.24% | ||
| FCFM | N/A |
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 298.66% | ||
| Cap/Sales | 257.57% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.79 | ||
| Quick Ratio | 2.73 | ||
| Altman-Z | -8.11 |
F-Score3
WACC7.63%
ROIC/WACCN/A
Cap/Depr(3y)208.17%
Cap/Depr(5y)571.74%
Cap/Sales(3y)624.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.94%
EPS Next Y16.12%
EPS Next 2Y2.32%
EPS Next 3Y7.1%
EPS Next 5Y9.22%
Revenue 1Y (TTM)109.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%464.19%
Revenue Next Year14.85%
Revenue Next 2Y106.36%
Revenue Next 3Y129.71%
Revenue Next 5Y106.53%
EBIT growth 1Y-15.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.89%
EBIT Next 3Y5.71%
EBIT Next 5Y19.91%
FCF growth 1Y-11.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.18%
OCF growth 3YN/A
OCF growth 5YN/A